GlassScriptPhysician profile
Zachary Swanson
NPI 1861624868
$2,247.94
in general payments reported to CMS, 2019-2025
10 companies · $587 in 2025
The $587 reported for 2025 was more than what 83% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $603 · 2023: $307 · 2024: $333 · 2025: $587.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,227.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,226.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $728.39 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $476.02 | 2023-2025 | Venapax, Sternalock Blu System, Sternalock 360 System |
| Abbott Laboratories | $416.07 | 2021-2025 | Epic |
| Astrazeneca Pharmaceuticals LP | $167.32 | 2021-2023 | Tagrisso |
| Abiomed | $139.79 | 2023 | Impella |
| Cvrx, INC. | $107.76 | 2025 | Barostim Neo System |
| Medical Device Business Services, INC. | $98.00 | 2021 | |
| Bolton Medical INC | $51.87 | 2023-2024 | Relay Thoracic Stent-Graft With Plus Delivery System, Treo Abdominal Stent-Graft System |
| Janssen Pharmaceuticals, INC | $37.40 | 2023 | Xarelto |
| Medtronic, INC. | $25.32 | 2023 | Avalus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zachary Swanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.